Accelerating nanodrug development in continuous flow systems using informed prediction models based on low-cost surrogate nanoparticles

arXiv cs.LG Papers

Summary

This arXiv paper presents a shape-constrained predictive modeling approach to estimate nanoparticle size and dispersity in continuous flow nanodrug production, reducing the need for extensive experimental screening.

arXiv:2608.05761v1 Announce Type: new Abstract: The development of nanotherapeutics often involves extensive empirical optimization due to the sensitivity of nanoparticle properties, such as size and polydispersity index (PDI), to minor changes in process parameters. Factors like formulation concentration, flow rates, and mixing ratios can significantly influence clinical efficacy and therapeutic outcomes. The absence of predictive mathematical frameworks has made iterative experimental screening necessary, increasing both costs and development time. This study introduces and validates a predictive modeling approach based on shape constraints, aiming to enhance the estimation of nanoparticle characteristics across various process conditions. Using controlled microfluidic methods, liposomes and lipid nanoparticles were systematically prepared under varying lipid concentrations, flow rates, and aqueous-to-organic mixing ratios. The shape-constrained model, informed by both experimental data and expert knowledge, was subsequently validated for a pharmaceutical application using minimal empirical data. Results reveal that shape-constrained modeling facilitates accurate prediction of nanoparticle size and dispersity, reducing the need for extensive experimental workflows. This framework supports rational and efficient process development for manufacturing nanomedicine systems.
Original Article
View Cached Full Text

Cached at: 08/07/26, 07:52 AM

# Accelerating nanodrug development in continuous flow systems using informed prediction models based on low-cost surrogate nanoparticles
Source: [https://arxiv.org/abs/2608.05761](https://arxiv.org/abs/2608.05761)
[View PDF](https://arxiv.org/pdf/2608.05761)

> Abstract:The development of nanotherapeutics often involves extensive empirical optimization due to the sensitivity of nanoparticle properties, such as size and polydispersity index \(PDI\), to minor changes in process parameters\. Factors like formulation concentration, flow rates, and mixing ratios can significantly influence clinical efficacy and therapeutic outcomes\. The absence of predictive mathematical frameworks has made iterative experimental screening necessary, increasing both costs and development time\. This study introduces and validates a predictive modeling approach based on shape constraints, aiming to enhance the estimation of nanoparticle characteristics across various process conditions\. Using controlled microfluidic methods, liposomes and lipid nanoparticles were systematically prepared under varying lipid concentrations, flow rates, and aqueous\-to\-organic mixing ratios\. The shape\-constrained model, informed by both experimental data and expert knowledge, was subsequently validated for a pharmaceutical application using minimal empirical data\. Results reveal that shape\-constrained modeling facilitates accurate prediction of nanoparticle size and dispersity, reducing the need for extensive experimental workflows\. This framework supports rational and efficient process development for manufacturing nanomedicine systems\.

## Submission history

From: Jochen Schmid \[[view email](https://arxiv.org/show-email/d1d70474/2608.05761)\] **\[v1\]**Thu, 6 Aug 2026 08:50:24 UTC \(7,480 KB\)

Similar Articles

Beyond Drug Discovery: The Nanotechnology Molecular Optimization (NMO) Benchmark

Hugging Face Daily Papers

The Nanotechnology Molecular Optimization (NMO) Benchmark introduces physics-based molecular design tasks replacing drug-discovery-focused metrics, aiming to drive scientific discovery in nanotechnology. The paper shows that advanced methods underperform simpler approaches on NMO, and proposes new baseline methods including a novel representation and domain-agnostic pretraining.

Design-CP: Context Parallelism for Design of Protein Nanoparticles

arXiv cs.LG

Design-CP introduces context-parallel inference strategies for RFdiffusion 3 that enable the all-atom design of large multimeric protein nanoparticles by distributing quadratic activations across multiple GPUs, making large-assembly protein design feasible on smaller GPU clusters.